This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Register by January 24 to save up to $1200

00
Days
00
Hrs
00
Mins
00
Secs

May 19-22, 2025

Manchester Grand Hyatt San DiegoSan Diego, CA

Rachael Anatol
Deputy Super Office Director, Office of Therapeutic Products, CBER at FDA
Speaker

Agenda Sessions

Panel Discussion: Addressing the Challenges of Bringing New Therapeutic Modalities to Market: Technical and Regulatory Considerations
20 May, 4:15pm
View Session

At this event

Prev

Next

Firoz Antia, PhD

Vice President, Oligonucleotide & Small Molecule CMC

Denali Therapeutics